Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index

Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index

Objective To investigate the impact of baseline and time‐varying factors on the risk of serious adverse events (SAEs) in patients during long‐term certolizumab pegol (CZP) treatment. Methods Safety data were pooled across 34 CZP clinical trials in rheumatoid arthritis (RA), axial spondyloarthritis (...

Полное описание

Библиографические подробности
Главные авторы:	Vivian P. Bykerk, Andrew Blauvelt, Jeffrey R. Curtis, Cécile Gaujoux‐Viala, Tore K. Kvien, Kevin Winthrop, Nicola Tilt, Christina Popova, Xavier Mariette, Boulos Haraoui
Формат:	Статья
Язык:	English
Опубликовано:	Wiley 2021-08-01
Серии:	ACR Open Rheumatology
Online-ссылка:	https://doi.org/10.1002/acr2.11259

Схожие документы

Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials
по: Tore K Kvien, и др.
Опубликовано: (2019-05-01)

Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
по: Vivian P. Bykerk, и др.
Опубликовано: (2023-02-01)

Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment
по: Jeffrey R. Curtis, и др.
Опубликовано: (2017-12-01)

Certolizumab pegol in the treatment of spondyloarthritis
по: Mariusz Korkosz
Опубликовано: (2014-09-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
по: Sh. F. Erdes
Опубликовано: (2016-02-01)

Certolizumab pegol in therapy for rheumatoid arthritis
по: Galina Viktorovna Lukina, и др.
Опубликовано: (2012-06-01)

Pegylation Reduces the Uptake of Certolizumab Pegol by Dendritic Cells and Epitope Presentation to T-Cells
по: Marie de Bourayne, и др.
Опубликовано: (2022-02-01)

Quantitation of certolizumab pegol by validated liquid chromatography methods
по: Clóvis Dervil Appratto Cardoso Júnior, и др.
Опубликовано: (2023-11-01)

EFFICACY OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF PSORIATIC ARTHRITIS
по: T. V. Korotaeva, и др.
Опубликовано: (2015-10-01)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
по: Mehmet Baysal, и др.
Опубликовано: (2018-09-01)

Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
по: M Connock, и др.
Опубликовано: (2010-10-01)

Treatment of pyoderma gangrenosum in pregnancy with certolizumab pegol
по: Lindsey J. Wanberg, и др.
Опубликовано: (2024-06-01)

Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis
по: Smolen, JS, и др.
Опубликовано: (2024)

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
по: Stéphane Paul, и др.
Опубликовано: (2020-07-01)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
по: Ruiz Garcia, V, и др.
Опубликовано: (2011)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
по: Ruiz Garcia, V, и др.
Опубликовано: (2014)

Experience with long-term use of certolizumab pegol (Cimzia)
по: Karine Arnoldovna Lytkina, и др.
Опубликовано: (2013-10-01)

Certolizumab pegol in treatment of Crohn's disease with perianal lesions
по: I.L. Khalif, и др.
Опубликовано: (2018-04-01)

Active axial spondyloarthritis: potential role of certolizumab pegol
по: Ranatunga S, и др.
Опубликовано: (2014-02-01)

Experience with long-term use of certolizumab pegol (Cimzia)
по: Karine Arnoldovna Lytkina, и др.
Опубликовано: (2013-10-01)

Certolizumab pegol – new option in the treatment of psoriatic arthritis
по: Maria Majdan, и др.
Опубликовано: (2014-07-01)

Certolizumab pegol w leczeniu reumatoidalnego zapalenia stawów
по: Piotr Wiland, и др.
Опубликовано: (2011-08-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF TAKAYASU ARTERITIS: THE FIRST EXPERIENCE AND PROSPECTS
по: P. I. Novikov, и др.
Опубликовано: (2018-07-01)

QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
по: Vera Nikolayevna Amirdjanova, и др.
Опубликовано: (2012-10-01)

Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
по: A. Spadaro, и др.
Опубликовано: (2013-07-01)

Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn's Disease
по: Wojciech Blonski, и др.
Опубликовано: (2012-04-01)

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice
по: O V Knyazev, и др.
Опубликовано: (2018-06-01)

Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis
по: Yael Sharon, и др.
Опубликовано: (2020-06-01)

Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials
по: Tanaka, Y, и др.
Опубликовано: (2023)

Certolizumab pegol in severe hidradenitis suppurativa in pregnancy: A case report
по: Paolo Gisondi, и др.
Опубликовано: (2025-01-01)

New aspects of the pharmacotherapy of rheumatoid arthritis: a focus on certolizumab pegol
по: Evgeniy L'vovich Nasonov, и др.
Опубликовано: (2011-02-01)

Successful treatment of dissecting cellulitis with certolizumab pegol in a pregnant patient
по: Nouf Almuhanna, MD, и др.
Опубликовано: (2023-09-01)

Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
по: A. A. Kubanov, и др.
Опубликовано: (2019-12-01)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
по: Henry Alistair I, и др.
Опубликовано: (2011-11-01)

Possible relationship between certolizumab pegol and arrhythmias: report of two cases
по: R. Talotta, и др.
Опубликовано: (2016-09-01)

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis
по: Emna Hannech, и др.
Опубликовано: (2021-06-01)

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study
по: Louis Bessette, и др.
Опубликовано: (2019-03-01)

A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis
по: Pablo Coto-Segura, и др.
Опубликовано: (2023-09-01)

Population PK modeling of certolizumab pegol in pregnant women with chronic inflammatory diseases
по: Denis Menshykau, и др.
Опубликовано: (2024-11-01)

New treatment possibilities for rheumatoid arthritis: the Russian experience in using certolizumab pegol
по: Dmitry Evgenyevich Karateev, и др.
Опубликовано: (2012-04-01)